• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴黎系统在报告HPV阳性尿路癌患者尿细胞学检查中的应用

Utility of The Paris System for Reporting Urinary Cytology in patients with HPV-positive urinary tract carcinoma.

作者信息

Tanaka Kara, Kayraklioglu Neslihan, Chan Emily, Ding Chien-Kuang C, Vohra Poonam

机构信息

Department of Pathology, University of California San Francisco, San Francisco, California, USA.

Department of Pathology, Stanford Medicine, Palo Alto, California, USA.

出版信息

Cancer Cytopathol. 2025 Jan;133(1):e22914. doi: 10.1002/cncy.22914. Epub 2024 Oct 15.

DOI:10.1002/cncy.22914
PMID:39403894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11695268/
Abstract

BACKGROUND

Human papillomavirus (HPV)-positive urinary tract carcinomas (UTCas) have distinct morphology and molecular features with potential treatment implications. Cytomorphologic analysis of these tumors on urine cytology specimens has not yet been reported. The authors evaluated the cytomorphologic findings of HPV-positive UTCa on urine cytology using The Paris System for Reporting Urinary Cytology (TPS) criteria.

METHODS

HPV-positive cases were identified by a retrospective review of surgical specimens that had UTCa confirmed by HPV in situ hybridization. Cases that had concurrent urine cytology were reviewed using TPS. Cytomorphologic features of high-grade urothelial carcinoma (HGUC) were evaluated as well as the presence of atypical squamous cells (ASCs) and basaloid features.

RESULTS

Sixteen cytology specimens from eight patients with HPV-positive UTCa were included. On original diagnosis, none of the cytology specimens were suggested to be HPV-associated. TPS diagnostic criteria identified eight cases with at least atypical findings, including five HGUC cases, one case that was suspicious for HGUC, and two atypical urothelial cases. Common cytomorphologic features included basaloid clusters (six of eight cases; 75%) and ASCs (four of eight cases; 50%) that matched the corresponding surgical specimens. Most cases exhibited urothelial cell hyperchromasia (seven of eight cases; 88%), and hypochromasia was a frequently observed variant (four of eight cases; 50%), either alone or in addition to hyperchromasia.

CONCLUSIONS

HPV-positive UTCa can be identified reliably as HGUC by using TPS criteria; however, these cases may not be recognized as HPV-associated. The presence of basaloid cells or ASCs can help suggest screening for HPV in urine specimens. Larger scale studies are warranted to validate cytomorphologic differences and determine the impact of HPV infection on clinical outcomes for patients with UTCa.

摘要

背景

人乳头瘤病毒(HPV)阳性的泌尿道癌(UTCa)具有独特的形态学和分子特征,对治疗可能具有潜在影响。目前尚未见对这些肿瘤尿液细胞学标本进行细胞形态学分析的报道。作者采用《巴黎报告泌尿系统细胞学系统》(TPS)标准评估了HPV阳性UTCa尿液细胞学的细胞形态学表现。

方法

通过回顾性分析经HPV原位杂交确诊为UTCa的手术标本,确定HPV阳性病例。对同时有尿液细胞学检查的病例采用TPS进行评估。评估高级别尿路上皮癌(HGUC)的细胞形态学特征以及非典型鳞状细胞(ASC)和基底样特征的存在情况。

结果

纳入了8例HPV阳性UTCa患者的16份细胞学标本。在最初诊断时,没有一份细胞学标本提示与HPV相关。TPS诊断标准确定了8例至少有非典型表现的病例,包括5例HGUC病例、1例疑似HGUC病例和2例非典型尿路上皮病例。常见的细胞形态学特征包括基底样细胞团(8例中的6例;75%)和ASC(8例中的4例;50%),与相应的手术标本相符。大多数病例表现为尿路上皮细胞色素沉着过度(8例中的7例;88%),色素减退是常见的变异表现(8例中的4例;50%),可单独出现或与色素沉着过度同时出现。

结论

采用TPS标准可将HPV阳性UTCa可靠地识别为HGUC;然而,这些病例可能未被识别为与HPV相关。基底样细胞或ASC的存在有助于提示对尿液标本进行HPV筛查。需要进行更大规模的研究来验证细胞形态学差异,并确定HPV感染对UTCa患者临床结局的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d671/11695268/1e436ff4beaa/CNCY-133-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d671/11695268/5a58ea47ec73/CNCY-133-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d671/11695268/f196a4753f11/CNCY-133-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d671/11695268/1e436ff4beaa/CNCY-133-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d671/11695268/5a58ea47ec73/CNCY-133-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d671/11695268/f196a4753f11/CNCY-133-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d671/11695268/1e436ff4beaa/CNCY-133-0-g001.jpg

相似文献

1
Utility of The Paris System for Reporting Urinary Cytology in patients with HPV-positive urinary tract carcinoma.巴黎系统在报告HPV阳性尿路癌患者尿细胞学检查中的应用
Cancer Cytopathol. 2025 Jan;133(1):e22914. doi: 10.1002/cncy.22914. Epub 2024 Oct 15.
2
Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.采用巴黎系统提高活检证实的上尿路尿路上皮癌尿细胞学标本的相关性。
Cancer Cytopathol. 2018 Jul;126(7):498-504. doi: 10.1002/cncy.22005. Epub 2018 Jun 21.
3
Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.应用巴黎系统报告尿细胞学检查后,高级别尿路上皮癌患者的风险分层得到改善。
Cancer Cytopathol. 2017 Jun;125(6):427-434. doi: 10.1002/cncy.21843. Epub 2017 Mar 8.
4
The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.上尿路尿路上皮标本的巴黎尿液细胞学系统:与活检和手术切除的比较分析
Cytopathology. 2018 Apr;29(2):184-188. doi: 10.1111/cyt.12505. Epub 2017 Dec 18.
5
Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?尿细胞学中 ThinPrep 和离心涂片中尿路上皮细胞的分样比较:我们是否需要调整《巴黎系统报告尿细胞学标准》?
Cancer Cytopathol. 2020 Feb;128(2):119-125. doi: 10.1002/cncy.22218. Epub 2019 Nov 27.
6
Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?高级尿路上皮癌中浆细胞样和微乳头状变异型的细胞组织学相关性:它们是否符合巴黎尿细胞学报告系统?
J Am Soc Cytopathol. 2021 Jan-Feb;10(1):20-24. doi: 10.1016/j.jasc.2020.05.013. Epub 2020 Jun 9.
7
Reclassification of Urinary Cytology according to the Paris System for Reporting Urinary Cytology Correlation with Histological Diagnosis.根据巴黎泌尿系统细胞学报告系统对泌尿系统细胞学进行重新分类及其与组织学诊断的相关性
Acta Cytol. 2024;68(6):544-554. doi: 10.1159/000541983. Epub 2024 Oct 15.
8
An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.巴黎系统的机构经验:从模糊术语到更客观的尿液细胞学报告标准的范式转变。
Cytopathology. 2017 Dec;28(6):509-515. doi: 10.1111/cyt.12448. Epub 2017 Aug 22.
9
Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.《巴黎尿细胞学报告系统》的实施提高了选择性上尿路细胞学诊断的准确性。
Cancer Cytopathol. 2024 Apr;132(4):242-249. doi: 10.1002/cncy.22792. Epub 2024 Jan 31.
10
Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.数字图像分析支持核质比截断值低于 0.7 用于尿液细胞学标本中高级尿路上皮癌的阳性和高级尿路上皮癌的可疑诊断。
Cancer Cytopathol. 2019 Feb;127(2):120-124. doi: 10.1002/cncy.22061. Epub 2018 Nov 5.

本文引用的文献

1
Atypical squamous cells in urine cytology are associated with a significant risk of high-grade malignancy.尿细胞学中的非典型鳞状细胞与高级别恶性肿瘤的显著风险相关。
Cancer Cytopathol. 2024 Aug;132(8):499-509. doi: 10.1002/cncy.22816. Epub 2024 Apr 13.
2
Clinicopathologic and Molecular Characterization of High-Risk Human Papillomavirus-Positive Carcinomas of the Urinary Tract.高危型人乳头瘤病毒阳性泌尿道癌的临床病理及分子特征
Arch Pathol Lab Med. 2025 Jan 1;149(1):30-38. doi: 10.5858/arpa.2023-0285-OA.
3
Are we on track for diagnosing high-grade urothelial carcinoma with a minimum quantity of five malignant cells in lower tract specimens? Critical analysis of The Paris System Quantitation Criteria.
我们是否有望通过在下尿路标本中检测到最少 5 个恶性细胞来诊断高级尿路上皮癌?对巴黎系统定量标准的批判性分析。
Cancer Cytopathol. 2023 Nov;131(11):708-715. doi: 10.1002/cncy.22749. Epub 2023 Aug 12.
4
The association between human papillomavirus and bladder cancer: Evidence from meta-analysis and two-sample mendelian randomization.人乳头瘤病毒与膀胱癌的关联:来自荟萃分析和两样本孟德尔随机化的证据。
J Med Virol. 2023 Jan;95(1):e28208. doi: 10.1002/jmv.28208. Epub 2022 Oct 25.
5
Bladder cancer and human papillomavirus association: a systematic review and meta-analysis.膀胱癌与人乳头瘤病毒的关联:一项系统评价和荟萃分析。
Infect Agent Cancer. 2022 Jan 21;17(1):3. doi: 10.1186/s13027-022-00415-5.
6
Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization.使用 RNAscope 检测尿路上皮癌中的 HPV 感染:临床病理特征。
Cancer Med. 2021 Aug;10(16):5534-5544. doi: 10.1002/cam4.4091. Epub 2021 Jun 23.
7
Nuclear hypochromasia: Shedding light on the "lightness" of high-grade urothelial carcinoma.核固缩:揭示高级别尿路上皮癌“浅色”的本质。
Diagn Cytopathol. 2021 Sep;49(9):1032-1035. doi: 10.1002/dc.24809. Epub 2021 Jun 9.
8
Prognostic value of HPV DNA in Urothelial Carcinoma of the Bladder: A Preliminary Report of 2-Year Follow-up Results.HPV 病毒 DNA 在膀胱癌中的预后价值:2 年随访结果的初步报告。
Urol J. 2021 Apr 28;19(1):45-49. doi: 10.22037/uj.v18i.6429.
9
Prognostic Significance of HPV DNA and p16 in Anal Cancer: A Systematic Review and Meta-Analysis.HPV DNA 和 p16 在肛门癌中的预后意义:系统评价和荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):703-710. doi: 10.1158/1055-9965.EPI-19-1259. Epub 2020 Feb 12.
10
The global burden of urinary bladder cancer: an update.全球膀胱癌负担:更新。
World J Urol. 2020 Aug;38(8):1895-1904. doi: 10.1007/s00345-019-02984-4. Epub 2019 Nov 1.